Tesi Raymond Joseph 4
4 · Inmune Bio, Inc. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Award
Option (right to buy)
2024-06-10+37,882→ 37,882 totalExercise: $8.72Exp: 2034-06-09→ Common Stock (37,882 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the INmune Bio Inc. 2021 Stock Incentive Plan. The option is 100% vested and exercisable as of the grant date.